发明名称 |
Use of nk-1 receptor antagonists for treating severe anxiety disorders |
摘要 |
The present invention provides the use of an orally active, long acting, CNS-penetrant NK-1 receptor antagonist in a medicament adapted for oral administration for the treatment or prevention of severe anxiety disorders without concomitant therapy with other anti-anxiety agents, methods of treatment using such an NK-1 receptor antagonist and pharmaceutical compositions comprising it. |
申请公布号 |
AU5752798(A) |
申请公布日期 |
1998.06.29 |
申请号 |
AU19980057527 |
申请日期 |
1997.11.25 |
申请人 |
MERCK SHARP & DOHME LIMITED |
发明人 |
RAYMOND BAKER;NEIL ROY CURTIS;JASON MATTHEW ELLIOTT;TIMOTHY HARRISON;GREGORY JOHN HOLLINGWORTH;PHILIP STEPHEN JACKSON;JANUSZ JOZEF KULAGOWSKI;NADIA MELANIE RUPNIAK;EILEEN MARY SEWARD;CHRISTOPHER JOHN SWAIN;BRIAN JOHN WILLIAMS |
分类号 |
A61K31/395;A61K31/4015;A61K31/438;A61K31/445;A61K31/451;A61K31/535;A61K31/5375;A61K31/5377;A61K31/675;A61K45/00;A61P25/22;C07D211/56;C07D265/30;C07D413/06;C07D491/10;(IPC1-7):A61K31/535 |
主分类号 |
A61K31/395 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|